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ntracoronary Optical Coherence Tomography:
Comprehensive Review
linical and Research Applications
iram G. Bezerra, MD, PHD,* Marco A. Costa, MD, PHD,* Giulio Guagliumi, MD,‡
ndrew M. Rollins, PHD,† Daniel I. Simon, MD*
leveland, Ohio; and Bergamo, Italy
ardiovascular optical coherence tomography (OCT) is a catheter-based invasive imaging system. Using
ight rather than ultrasound, OCT produces high-resolution in vivo images of coronary arteries and de-
loyed stents. This comprehensive review will assist practicing interventional cardiologists in under-
tanding the technical aspects of OCT based upon the physics of light and will also highlight the
merging research and clinical applications of OCT. Semi-automated imaging analyses of OCT systems
ermit accurate measurements of luminal architecture and provide insights regarding stent apposition,
verlap, neointimal thickening, and, in the case of bioabsorbable stents, information regarding the
ime course of stent dissolution. The advantages and limitations of this new imaging modality will be
iscussed with emphasis on key physical and technical aspects of intracoronary image acquisition, cur-
ent applications, deﬁnitions, pitfalls, and future directions. (J Am Coll Cardiol Intv 2009;2:1035–46)
2009 by the American College of Cardiology Foundatione
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woncepts in Biophotonics
he fundamental principles of optical coherence
omography (OCT) evolved from optical 1-dimen-
ional low-coherence reflectometry, which uses a
ichelson interferometer and a broadband light
ource. In 1991, the addition of transverse scan-
ing (B-scan), enabled 2-dimensional imaging of
he retina (1). This technique was named OCT by
ames Fujimoto and rapidly expanded to numerous
iomedical and clinical applications. Intravascular
CT requires a single fiberoptic wire that both
rom the *Harrington-McLaughlin Heart & Vascular Institute, Univer-
ity Hospitals Case Medical Center, and the †Department of Biomedical
ngineering, Case Western Reserve University School of Medicine,
leveland, Ohio; and the ‡Cardiovascular Department Ospedali Riuniti
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onsulting honoraria from Lightlab. Dr. Costa received research grants
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ightlab, and Boston Scientific. Dr. Simon received research grants from
edtronic Vascular and Cordis/Johnson & Johnson.M
anuscript received May 15, 2009; revised manuscript received June 16,
009, accepted June 25, 2009.mits light and records the reflection while simul-
aneously rotating and being pulled back along the
rtery.
The coronary OCT light source uses a band-
idth in the near-infrared spectrum with central
avelengths ranging from 1,250 to 1,350 nm.
lthough longer wavelengths provide deeper tissue
enetration, the optimal choice of wavelength in
n arterial vessel is also defined by tissue absorption
haracteristics and the refractive index of the in-
erface between the catheter and vessel wall. Cur-
ent intravascular OCT systems use a central wave-
ength of approximately 1,300 nm. Using this
avelength the tissue penetration is limited to 1 to
mm as compared with 4 to 8 mm achieved by
ntravascular ultrasound (IVUS), with the excep-
ion of calcified lesions in which sound has a
imited penetration.
The image is formed by the backscattering of
ight from the vessel wall or the time it takes for
mitted light to travel between the target tissue and
ack to the lens, producing an “echo time delay”
ith a measurable signal intensity or “magnitude.”
ultiple axial scans (A-lines) are continuously
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1036cquired as the imagewire rotates and a full revolution
reates a complete cross section of the vessel.
It is important to note that the speed of light (3  108
/s) is much faster than that of sound (1,500 m/s), and,
herefore, interferometry techniques are necessary to mea-
ure the backscattered signal since a direct quantification
annot be achieved on such a time scale. The interferometer
ses a fiberoptic coupler similar to a beam splitter, which
irects one-half of the beam to the tissue and the other
ne-half to the reference arm. The reference arm of a
ime-domain optical coherence tomography (TD-OCT)
ystem consists of a mirror moving at calibrated distances to
roduce known echo delays. The reflected signal returning
rom the tissue and reference arms are recombined in the
ber-coupler, and their interference fringes are detected by
photodetector. The general scheme of an intravascular
CT system is shown in Figure 1.
The axial resolution, determined by the light wave-
length, ranges from 12 to 18
m, compared with 150 to 200
m for IVUS. The lateral res-
olution and depth of focus are
decoupled from the axial reso-
lution and defined by the spot
size focused by the lens in the
sample arm. The lateral resolu-
tion in catheter-based OCT is
typically 20 to 90 m as com-
pared with 150 to 300 m for
IVUS. For faster image acqui-
sition, the ideal choice is to
accelerate the acquisition time
of each A-line. This process
generates faster cross-sectional
imaging, in turn resulting in a
higher number of frames per
econd, which ultimately yields a faster pullback. How-
ver, further improvement in speed for time-domain
CT systems is physically limited by generating a fast
ptical delay in the reference arm and the tradeoff
etween the imaging speed and sensitivity. Newer-
enerations of intravascular OCT systems circumvent
his limitation by using a fixed mirror with a variable
requency light source or “swept-laser.” This method,
ermed frequency or Fourier-domain optical coherence
omography (FD-OCT), allows the simultaneous detec-
ion of reflections from all echo time delays, making the
ystem significantly faster (2). There are 2 types of
D-OCT systems that differ in their method of data
xtraction from the interferometer: optical frequency
omain imaging also known as swept-source OCT, or a
pectral domain OCT. The specific features of each
ystem of transformation are outside the scope of this
bbreviations
nd Acronyms
-line  axial line (scan)
D-OCT  frequency or
ourier-domain optical
oherence tomography
EL/EEL  internal elastic
amina/external elastic
amina
VUS  intravascular
ltrasound
IH  neointimal hyperplasia
CT  optical coherence
omography
D-OCT  time-domain
ptical coherence
omographyrticle. A diagram of the main components of the (D-OCT and FD-OCT systems are shown in Figure 1
nd their features contrasted in Table 1.
ommercial OCT Systems
he first commercially available OCT system was the
ightLab M2 TD-OCT Imaging System (LightLab,
estford, Massachusetts). Recently an FD-OCT system
C7 XR, LightLab) has become commercially available in
he European Union, Asia, and South America. In the
2/M3 systems, images are recorded by an ImageWire
LightLab), a general purpose, single-mode, fiberoptic
ire that rotates inside a fluid-filled polymer tube. A
icro lens assembly at the distal end is 1 mm in length
nd 125 m in diameter (similar to the fiber itself). This
ssembly focuses and reflects the light beam at 80° from
he fiber’s axis to allow circumferential imaging of the
essel. The wire is attached to an automated pullback
ngine integrated with the console. The external diame-
er of the imagewire is 0.019 inches and is fused to a short
egment of a standard 0.014-inch guidewire at the distal
nd. An over-the-wire low-pressure occlusion balloon
atheter (Helios, Goodman, Nagoya, Japan) with distal
ush ports is used to infuse saline or Ringer’s Lactate at
pproximately 0.5 ml/s to selectively displace blood
uring imaging acquisition. Blood must be completely
emoved, as any amount of residual red blood cells causes
ignificant signal attenuation. Because of safety concerns,
he occlusion time is limited by the manufacturer to 30 s.
imilar balloon occlusion techniques are used with an-
ioscopy. The new FD-OCT systems can acquire 100
rames/s, reaching pullback speeds up to 20 mm/s with
he potential to scan 4- to 6-cm length epicardial coronary
essels in 5 s (3,4). Accelerated pullback speeds permit
he use of a single, high rate (4 cc/s) bolus injection of
ontrast to produce a blood-free environment, thereby
liminating the need for balloon occlusion (3,4) (Table 1).
he Lightlab FD-OCT system is equipped with a tunable
aser light source with sweep range of 1,250 to 1,370 nm.
he optical fiber is encapsulated within a rotating torque
ire built in a rapid exchange 2.6-F catheter compatible
ith 6-F guides. This system has been already tested in
umans in Europe and Japan, and is currently under
ood and Drug Administration evaluation. Terumo
Terumo Corporation, Tokyo, Japan) is developing an
D-OCT system, which has a 2.4-F shaft. Volcano
Volcano Corporation, Rancho Cordova, California) is
he third FD-OCT system under development with a
apid-exchange nitinol hybrid drive shaft (5).
CT Imaging Acquisition Technique
espite its guidewire-like profile, the OCT ImageWire
Lightlab TD-OCT) is not designed to be advanced into
t
i
c
e
6
a
c
g
a
i
c
t
0
p
w
c
e
s
p
t
a
O
o
m
c
6

n
o
v
s
e
T
v
a
r
a
T
F
p
a
c
u
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S , V O L . 2 , N O . 1 1 , 2 0 0 9 Bezerra et al.
N O V E M B E R 2 0 0 9 : 1 0 3 5 – 4 6 Intracoronary OCT
1037he coronary artery as a stand-alone device. Rather, the
magewire is inserted using an over-the-wire balloon
atheter (Helios). The Helios balloon has a maximum
xternal diameter of 1.5 mm and is compatible with large
-F guiding catheters (0.071-inch inner diameter). It is
dvanced distally to the segment of interest over a
onventional angioplasty guidewire (0.014-inch). The
uidewire is then exchanged with the OCT ImageWire,
nd the occlusion balloon is pulled back and repositioned
n a healthy proximal segment. The balloon is highly
ompliant and is inflated at minimal pressure that allows
otally clean imaging from blood, usually between 0.4 to
.7 atm with a dedicated inflator. A contrast injector
ump with a warming cuff is set at 0.5 cc/s infusion,
Figure 1. Scheme of TD-OCT and FD-OCT
A schematic representation of time-domain optical coherence tomography (TD
(FD-OCT, right panel depicts a subtype of FD-OCT called optical frequency do
ter to detect echo time delays of light. The interferometer uses a beamsplitter
The reference arm in TD-OCT is mechanically scanned (by a moving mirror) in
source is frequency swept, the interference of the 2 light beams (tissue and re
ference of the signal ultimately provides amplitude and frequency data. In the
increases in the speed of image acquisition.
Table 1. Comparison Between TD-OCT and Prototype FD-OCT*
Specifications TD-OCT FD-OCT
Axial scans/s 5,000–10,000 100,000
Lines/frame 200 500–1,000
Max. frame rate, fps 20 200
Max. pullback speed, mm/s 3 20
Scan diameter (FOV), mm 6.8 6–11
Axial resolution, m 15 10–15
Lateral resolution, m 90 20–40
Tissue penetration, mm 1.5–3 2–3.5
Balloon occlusion Highly recommended Optional
Catheter size, mm 0.48 0.8–1.0
*Values are approximate; TD-OCT specifications refer to the Lightlab time-domain optical coher-
ence tomography (TD-OCT) system (M2/M3).
FD-OCT  frequency or Fourier-domain optical coherence tomography; FOV  field of view;pTD-OCT time-domain optical coherence tomography.hich can be increased to up to 1.0 cc/s until blood is
ompletely cleared. The solution is injected through the
nd-hole distal port of the occlusion balloon catheter and
hould start several seconds before balloon occlusion. The
ullback speed can be adjusted from 0.5 to 3.0 mm/s, and
he entire imagewire is pulled from distal to proximal
long the coronary artery. In the next-generation FD-
CT systems, imaging can be performed without balloon
cclusion. The pullback speed can reach up to 20 to 40
m/s and is performed during contrast injection (4
c/s) to assure complete blood clearance. Imaging of 4 to
cm of coronary artery segments can be achieved with
15 cc of contrast per pullback. For nonocclusion tech-
iques, iodinated contrast media is preferred over saline
r Ringer’s lactate because of the advantage of high
iscosity solutions in completely removing blood.
Operators should be aware of the vessel size range
uitable for OCT imaging, particularly with the first gen-
ration devices, ideally between 2.0 to 3.75 mm in diameter.
he upper limit is restricted by the scan diameter (field of
iew) and fold-over artifact (specific to FD-OCT systems),
ddressed later. In fact, “out-of-screen” loss of image rep-
esents the most common technical exclusion of frame
nalysis in the clinical trials examined in our core laboratory.
he field of view was significantly enlarged in the new
D-OCT system (Table 1). The need for a proximally
laced balloon in conventional TD-OCT imaging limits its
bility to evaluate ostial and highly proximal disease in the
oronary arteries since inflation of the Helios balloon in an
nprotected left main or diseased segment should not be
left panel) and frequency or Fourier-domain optical coherence tomography
imaging [OFDI OCT]). Both systems use a reference arm and an interferome-
ing the light into a measurement arm (tissue sample) and a reference arm.
to produce a time-varying time delay. In the FD-OCT, because the light
e) oscillates according to the frequency difference. In both systems the inter-
CT system, all echo delays are acquired simultaneously enabling signiﬁcant-OCT,
main
, divid
order
ferenc
FD-Oerformed. Other potential sources of image distortion
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1038nclude excessive vessel tortuosity and the presence of
xuberant collateral flow. Studies comparing OCT versus
VUS suggest that TD-OCT is safe and can be performed
ith success rates at least comparable with IVUS (6–8).
ome transient events, such as chest discomfort and ST-T
hanges, were observed during imaging procedures with
CT or IVUS. Neither hemodynamic instability nor ven-
ricular tachyarrhythmia was observed (7). The feasibility
nd safety of the larger catheter-based FD-OCT systems
emains to be established in future trials.
itfalls in imaging post-processing and interpretation
-offset. Imagewires have minute differences in their optic
ath lengths. The Z-offset is a manually adjustable image
alibration, which is critical for accurate measurements. In
he current LightLabs TD-OCT system, the catheter di-
meter acts as a reference for optimal Z-offset determina-
ion within an image frame. The 4 marks or fiduciaries
hould align to fit the outer surface of the catheter. If the
atheter is not well visualized, calibration is performed in a
rame where the catheter is in contact with the vascular
urface by adjusting the fiduciaries to align the vessel wall.
Figure 2. Most Frequent Artifacts
Cross-sectional image of the human coronary artery. Most frequently observed
Eccentric image wire can distort stent reﬂection orientation, the struts align to
Saturation artifact, some scan lines have a streaked appearance. (D) Sew-up ar
in misalignment of the image. (E) Air bubbles, formed inside the catheter, pro
bright structures, between 5 and 9 o’clock. (F) Fold over artifact (Fourier-doma
the cross section is located at the level of a side branch (blue line).he operator should monitor these patterns throughout thentire pullback since additional adjustments may be neces-
ary. The majority of corrections are typically made in the
rst 10 mm of the pullback image. In next-generation
D-OCT catheters, a semitransparent catheter around the
ptic fiber is more suitable for direct calibration. We have
bserved that a 1% change in the magnitude of the ideal
-offset can result in a 12% to 14% error in area measure-
ents. Small changes in magnitude can also amplify con-
our distortion, which may result in misinterpretation of the
mage.
rtifacts. Some OCT artifacts are common to both OCT
nd IVUS, and others are unique to OCT imaging systems.
ost of these artifacts will not substantially compromise
linical interpretation of the image, if restricted to few
oncontinuous frames, but may render imprecise assessment
f plaque characteristics or measurements (Fig. 2).
. Residual blood attenuates the OCT light beam and may
defocus the beam if red cell density is high. This will
reduce brightness of the vessel wall, especially at large
radial distances from the ImageWire. If the lumen
cts: (A) incomplete blood displacement, resulting in light attenuation. (B)
the imaging wire “sunﬂower effect” and are elongated “merry-go-round.” (C)
result of rapid wire or vessel movement along 1 frame formation, resulting
n attenuated image along the corresponding arc. Detail reveals the bubbles,
tical coherence tomography system), the longitudinal view demonstrates thatartifa
ward
tifact:
duce a
in opsurface is still clearly defined, the presence of diluted
23
4
5
6
7
ffect.
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1039blood does not appear to affect area measurements. Care
should be taken to avoid mistakenly labeling residual
blood artifact as thrombus or some other specific intra-
vascular finding.
. Nonuniform rotational distortion is the result of varia-
tion in the rotational speed of the spinning optical
fiber. It is usually produced by vessel tortuosity or by
an imperfection in the torque wire or sheath interfer-
ing with smooth rotation of the optical fiber, which
can result in focal image loss or shape distortion.
Fortunately, this seems to occur less frequently than in
IVUS imaging, perhaps as a result of the smaller
profile and simplified rotational mechanics of OCT
wires.
. Sew-up artifact is the result of rapid artery or imag-
ing wire movement in 1 frame’s imaging formation,
leading to single point misalignment of the lumen
border.
. Saturation artifact occurs when light reflected from a
highly specular surface (usually stent struts) produces
signals with amplitudes that exceed the dynamic range
of the data acquisition system (Fig. 2). This should be
kept in mind when defining the stent surface. We
measured the average “normal” blooming of a stainless
steel stent from 2,250 struts in 471 cross-sectional
OCT images. The mean measured thickness was 37 
Figure 3. Malapposition Quantification
Cross-section image illustrating various levels of stent strut protrusion. Strut lo
sured distance from the surface of the blooming to the lumen contour is high
ing (the stent surface should be, theoretically, located at one-half the distance
Scientiﬁc, Natick, Massachusetts) stent, the total, estimated, strut thickness  1
ing  18 m). The measured distance was 200 m conﬁrming a malapposed
gated on the struts distant from the wire (5 and 7 o’clock), “merry-go-round” e8 m (9). These values are important particularly formalapposition quantification since the blooming
thickness value needs to be considered in addition to
stent and polymer thickness.
. Fold-over artifact is more specific to the new generation
of FD-OCT. It is the consequence of the “phase
wrapping” or “alias” along the Fourier transformation
when structure signals are reflected from outside the
system’s field of view. Typical examples are side branch
and large vessels.
. Bubble artifact occurs when small gas bubbles are formed
in the silicon lubricant used to reduce friction between
the sheath and the revolving optic fiber in TD-OCT
systems. It can attenuate the signal along a region of the
vessel wall, and images with this artifact are not suitable
for tissue characterization.
. Artifacts related to eccentric wire position. Eccentricity of
the imagewire in the vessel lumen can influence many
aspects of the image interpretation. This phenomenon
is likely secondary to imaging sweep speed, and is
more pronounced with an eccentric imagewire posi-
tion, leading to longer distance between each A-line
and consequently decreasing the lateral resolution, and
has been dubbed the “merry-go-round” effect (Fig. 3).
A byproduct of rotational scanning, the reflection
from metallic stent struts align toward the imaging
wire, akin to sunflowers aligning to the sun or a
at 7 o’clock is malapposed (detail). Malapposition is deﬁned when the mea-
n the total thickness of the stent strut  polymer  one-half of the bloom-
blooming thickness). In this particular case of a Taxus Express (Boston
(strut thickness  132 m  polymer  16 m  one-half of the bloom-
Because of the eccentric wire position, the blooming component is elon-cated
er tha
of the
64 m
strut.“sunflower” effect. This effect is pronounced with
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1040eccentric wire position, as it can display strut reflec-
tions almost perpendicular to the lumen surface in
oblique regions from the wire. This may have impor-
tant future implications in the serial assessment of
strut length, particularly when evaluating the degra-
dation of bioabsorbable stents.
linical Applications
iagnostic assessment of coronary atherosclerosis. Ac-
nowledging the lack of prospective studies and appropriate
nimal models to define vulnerable plaque (i.e., rupture-
rone), our current understanding of plaque biology sug-
ests that 80% of clinically evident plaque rupture origi-
ates within an inflamed thin-capped fibroatheroma (10).
laques containing calcium nodules are associated with
10% of clinical events, and plaque that does not fall into
ither category is associated with 20% of clinical athero-
hrombosis. Superficial plaque erosion may comprise a
ortion of these events, especially in women and diabetic
atients. Because plaque erosion does not have a typical
Figure 4. Fibrotic Cap Measurement
Representative cross section containing atherosclerotic plaque with different ﬁ
Thick ﬁbrotic cap, measuring 250 m.ellular or anatomical signature, it is currently difficult to
rospectively identify those plaques at risk by existing
maging methods. Clinical plaque erosion has been reported
y OCT in a similar frequency to pathologic studies (11,12).
Thin-capped fibroatheromas are characterized by 3 es-
ential components: a lipid core, inflammatory cell cap
nfiltration, and a thin fibrous cap. While OCT does not
urrently have the depth to quantify large lipid cores, its
igh resolution allows precise visualization and quantifica-
ion of the thin fibrous cap (11,13).
IBROUS CAP. While seminal post-mortem investigations
ave suggested that a cap thickness 65 m (14) is
ssociated with plaque rupture, OCT has demonstrated that
atterns of plaque rupture and fibrous cap thickness vary
idely. Illustrating this heterogeneity, OCT showed 93% of
he culprit plaques in patients presenting with acute myo-
ardial infarction triggered by exertion had rupture at the
houlder, where the average cap thickness was 90 m. In
ontrast, 57% of acute myocardial infarction patients who
xperienced symptoms at rest had plaque rupture in the
houlder with an average cap thickness of 50 m (15). OCT
cap thicknesses. (A and B) Thin ﬁbrotic cap, measuring 40 m. (C and D)brotic
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1041rovides the potential for fibrous cap plaque measurement
Fig. 4) and was recently used to demonstrate a significant
ncrease in cap thickness in patients taking a statin versus a
ontrol group (16).
NFLAMMATION. The large size of macrophages and their
igh lipid content yield strong optical signals (17–19).
lusters of macrophages can appear as bright spots along
he fibrous cap. However, data supporting OCT’s capability
o quantify macrophages used raw (linear) OCT data from
arly generation systems (18). The accuracy and validation
f current clinical OCT systems for the evaluation of
acrophages remains to be demonstrated.
IPID NECROTIC CORE. The lipid/fibrous tissue interface
auses a surrounding border of high superficial backscatter-
ng. However, light does not penetrate deeply into the
ecrotic core, and is further absorbed by the lipid tissue
roviding a subsequent region of low or no signal casting the
ascular wall beyond in shadow. This makes the extent of
he lipid pool or vascular remodeling difficult to quantify.
ALCIUM NODULES. In contrast to ultrasound, light pene-
rates calcium and OCT depicts calcium with well-defined
oundaries (Fig. 5). One OCT study has reported a sensi-
ivity of 96% and specificity of 97% to detect calcified
odules (13).
HROMBUS. Previous studies have suggested that it is
ossible to identify thrombus by OCT and even discrim-
nate between red and white thrombus, as confirmed by
istopathologic correlation (20) (Table 2). The sensitivity
f OCT to detect thrombus appears to possibly be higher
han that of ultrasound (11,21), but these studies were
onducted in a selected population with a high pre-test
robability of thrombus. In our experience of 500
etailed OCT coronary stent analyses, the discrimination
f thrombus from other potentially abnormal intralumi-
al images can be ambiguous, particularly when these
nalyses are blinded. Overall, OCT may possess diagnos-
ic advantages compared with both IVUS and angioscopy
n the assessment of culprit lesions. Plaque rupture was
dentifiable in 73% of OCT images compared with 40%
nd 47%, respectively, for IVUS and angioscopy; more-
ver, plaque erosion was almost exclusively identified by
CT (23%) in a cohort of patients with acute myocardial
nfarction (11). The same study reported thrombus iden-
ification in all cases by OCT and angioscopy, but only in
3% of IVUS images.
CT-guided coronary intervention. Assessment of lumen
eometry remains the cornerstone of intravascular imaging
riteria to evaluate disease severity and guide interventional
rocedures. Minimal lumen area, percentage lumen ob-
truction, percent neointimal hyperplasia (NIH), stent ap-
osition, stent expansion, minimal stent cross section area,
umen gain, late lumen loss, and restenosis are all based on
he evaluation of the lumen-vessel/stent interface (22–30).
CT images provide a clear depiction of the boundaries retween lumen and vessel. OCT’s ability to penetrate and
elineate calcium in the vessel wall makes it well suited to
uide complex interventional strategies in vessels with
uperficial calcification (Fig. 6D). It is important to note
hat IVUS-guided vessel dimensions and criteria for
ercutaneous coronary intervention may vary between
ifferent imaging modalities or even different quantifica-
ion software (31).
We and others have demonstrated the higher sensitivity
f OCT compared with IVUS for malapposed strut assess-
ent (32,33). Plaque protrusion and stent-edge dissection
re other common intervention-related parameters readily
isible on OCT images, although their clinical impact
Figure 5. Optical Coherence Tomography: Histology Correlation
(A) Fibrotic plaque: characterized by high signal (high backscattering) and
low attenuation (deep penetration). (B) Predominantly calciﬁed plaque: cal-
ciﬁed regions have a sharp border, low signal, and low attenuation permit-
ting deeper penetration. (C) Lipid-rich plaque: the lipid core has a diffuse
border. High light attenuation results in poor tissue penetration (in contrast
to calciﬁed regions). The overlying ﬁbrotic cap can be readily measured; in
this case a thick cap (200 m) is present. ‡Calciﬁed region; *lipid core.
Courtesy of LightLab Imaging (C. Y. Xu and J. M. Schmitt).emains to be assessed.
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1042esearch Applications of Intravascular OCT
nd point for clinical trials. Stent-strut coverage and appo-
ition have been linked to the risk of stent thrombosis
34,35), and recent DES clinical trials, such as the
DESSA (OCT for DES SAfety) study, have selected
hese variables as their primary end point (36). Histologic
tudies have revealed that IVUS does not have adequate
esolution to detect the thinnest layers of tissue coverage
37), and the perception that lack of NIH by IVUS is
ynonymous to an uncovered strut needs to be reconsidered.
n a sub-analysis of the ODESSA trial, we identified 20 of
Figure 6. Coronary Imaging Acquired With an FD-OCT System
A longitudinal reconstruction (lower panel) and cross-sectional images (uppe
phy (FD-OCT) system (Lightlab) at 20 mm/s immediately after stent implantatio
(A) Distal edge dissection, with corresponding longitudinal view (arrows). (B)
view. (C) Malapposed struts between 11 and 1 o’clock, with corresponding lon
Table 2. General Characteristics of the Different Tissues by OCT
Tissue Backscattering Attenuatio
Calcium  
Lipid  
Fibrotic  
Red thrombus  
White thrombus  
Media layer  
IEL/EEL  
IEL/EEL internal elastic lamina/external elastic lamina; OCT optical coherence tomography;age, with corresponding longitudinal view (arrows).50 stented segments with no detectable NIH by IVUS, but
ad neointimal coverage ranging from 67% to 100% by
CT (38). In contrast to the relatively homogenous lack of
IH detected by IVUS, OCT revealed a highly heteroge-
eous response to DES, which varied even within the same
ross-sectional image.
trut-level analysis. Our current method of strut-level
nalysis stratifies struts into 4 main categories: covered-
mbedded, covered-protruding (into the lumen but cov-
red), uncovered-apposed, and malapposed. A semi-
utomated stent contour algorithm applies 360 radial
hords for detailed quantification of NIH thickness at
ls) acquired with a frequency or Fourier-domain optical coherence tomogra-
te that a 5-cm coronary segment was imaged with a 3-s contrast injection.
xpanded and well-apposed stent struts, with corresponding longitudinal
nal view (arrows). (D) Proximal calciﬁed plaque with minimal ﬁbrous cover-
General Aspects
Sharp borders, low signal with heterogeneous regions
Irregular borders, superﬁcial high signal followed by very low signal
Homogeneous bright tissue
Superﬁcial signal rich, low penetration, signal-free shadowing
Signal rich, more penetration than for red thrombus
Low signal region, limited by 2 signal-rich band (IEL/EEL)
High signal band (20 m)
moderate; highr pane
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1043very degree of the cross section (Fig. 7). The continuous
ampling obtained by OCT also represents an advantage
ver standard histopathology, which evaluates cross sec-
ions in intervals of 2 to 3 mm (39). Taking advantage of
uch OCT features, one may be able to gather enough
nformation from a relatively small patient cohort to
uide drug and device industry before embarking on large
opulation trials.
Our understanding of DES healing in patients with
T-segment elevation myocardial infarction was restricted
o post-mortem data (39). A high-rate (49%) of uncovered
truts was observed in previous pathology studies, but the
imited number of specimens (n  25) and inherent
election bias of such studies precluded any definitive
onclusions. The OCT substudy of the HORIZONS (Har-
onizing Outcomes with Revascularization and Stents in
Figure 7. Quantitative Stent Analysis
(A) Representative frame depicting a Core-Lab area measurement and strut lev
age and quantitative measurement from the surface of the blooming artifact t
frame (C to N refer to labeled struts): covered struts (E to G), uncovered appos
the automatic 360° chord system, applied between the stent and lumen conto
and stent detection: stent struts (green dots) and lumen contour (red line). (
crimination of the struts from the surrounding tissue. (C and D) LightLab’s aut
LightLab Imaging (C. Y. Xu and J. M. Schmitt), images obtained at Wakayama UMI) trial (40) evaluated 117 patients (199 stents) in a vrospective, randomized and blinded manner. Stent struts
ere analyzed at every 0.3 mm at 13-month post-stenting
nd revealed a higher percentage of strut coverage in both
are-metal stents and drug-eluting stents (98.9% vs. 94.3%,
 0.001) compared with autopsy studies (9).
An important limitation of OCT is the limited precision
n discriminating the different kinds of tissue coverage of
tents (i.e., endothelium, smooth muscle cells, extracellular
atrix). Future studies using histopathologic correlations
re needed to define “normal” and “abnormal” stent healing
nd vessel wall passivation. Importantly, the spatial resolu-
ion of current OCT systems is insufficient to detect cell
ayer thickness 20 m on the stent surface, thereby
recluding a precise distinction between “true lack of cellu-
ar coverage” versus 3 to 5 cell layer coverage of stent struts.
n a research basis, OCT is well suited for studying
lysis. Strut level analysis consists of a qualitative assessment for strut cover-
lumen contour. A heterogeneity of strut coverage is observed within a single
uts (H to J), and malapposed struts (K to N, C and D). (B) Magniﬁcation of
llowing a detailed measurement of the stent coverage. (C) Automatic lumen
face 3-dimensional view: the highly reﬂective stent surface allows easy dis-
d stent strut analysis software (R&D program, not released) courtesy of
sity (Prof. Akasaka). NIH  neointimal hyperplasia.el ana
o the
ed str
urs, a
D) En
omateascular healing over time. In the ongoing OCTAXUS
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1044OCT Taxus) study, OCT imaging is being performed at 3-
nd 9-month intervals after stent deployment. Serial studies
r observational studies at defined time points may also be
elpful in clarifying the role of adjunctive pharmacology in
he context of vascular healing (e.g., the intensity and
uration of antiplatelet therapy).
he Future Outlook
he future of OCT will include advancements in anatom-
cal and functional assessment of lesions for the interven-
ional cardiologist.
natomical assessment. An advanced edge detection algo-
ithm that enables automated stent strut identification is
lready available in the research laboratory and is likely to
ppear in the cathlab in the near future. A similar concept is
lso being applied to help facilitate tissue characterization
e.g., sharp edges of calcium can be differentiated from
iffuse lipid appearance) (Table 2) (Fig. 5). Texture analysis
f OCT images may also help facilitate tissue characteriza-
ion, (e.g., “fractal analysis” uses a computational method of
alculating the extent of entropy or randomness found in the
issue image). Polarization takes advantage of the random
cattering found in some tissues and reproducible birefrin-
Figure 8. Comparison Between OCT Capabilities and Others’ Imaging Meth
Graphic representation of tissue penetration versus spatial resolution of optica
boxes represent the maximal resolution and depth achieved with current tech
etration for each of the technologies. The dashed box illustrates the hypothet
detect neointimal hyperplasia observed after drug-eluting stent (NIH) usually e
thickness can only be assessed in vivo by OCT. However, current OCT systems
single cell endothelial layers can only be assessed in vitro by microscopy or ad
the process; Endothelium  single intimal cell layer; Fibrous Cap  thicknessence found in other highly organized tissues (a property of uollagen-rich tissue). Perhaps this may serve as a future
ndex of plaque stability since this organized fibrous tissue
eems to be protective. Ultra-high resolution OCT, as the
ame suggests, aims to resolve images to 10 m. Strate-
ies to accomplish this include ultra-broadband light
ources, lower central wavelengths (41), femtosecond lasers
42–45), and multiple superluminescent diodes.
unctional assessment. Contrast enhanced and molecular
CT is an evolving field based on the development and use
f nanoparticles, microspheres, and absorbing dyes to in-
rease the local properties of scattering and absorption of
ight in targeted tissues. Detection of Doppler-like signals
sing a TD-OCT ImageWire may permit a biophotonic
ersion of the flow wire, thereby allowing integration of
hysiology and anatomical assessment using a single device.
onclusions
CT enhances imaging resolution (Fig. 8) that may permit
he evaluation of clinical (e.g., luminal measurements during
CI) and research (e.g., fibrous cap thickness and strut level
nalysis) parameters for the interventional cardiologist. The
ersatility of the physical properties of light position OCT
s an imaging modality could be useful for improving our
rence tomography (OCT) compared with other imaging methods. The solid
ies. The larger open boxes represent the range of resolution and tissue pen-
pabilities of future OCT systems. Resolution requirements to accurately
s the capabilities of intravascular ultrasound (IVUS). Similarly, ﬁbrous cap
t suitable to assess tissue at depths beyond 2 mm. Currently, evaluation of
bench-top OCT systems. Atherosclerosis  early and advanced stages of
related to thin cap ﬁbroatheroma.ods
l cohe
nolog
ical ca
xceed
are no
vancenderstanding of the vascular biology of atherothrombosis
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1045nd assisting in our performance of PCI procedures. How-
ver, routine clinical use of OCT will require further clinical
rials to validate the technology, establish standard defini-
ions/measurements, and to test its safety and utility in
mproving clinical outcomes.
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